Zhen Su, M.D., M.B.A
Board Member
Karyopharm Therapeutics Inc. (KPTI)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Zhen Su, M.D., M.B.A
Zhen Su, M.D., M.B.A is recorded as Board Member at Karyopharm Therapeutics Inc. (KPTI). Karyopharm Therapeutics Inc. reported in an 8-K filed September 1, 2023 that Zhen Su, M.D., M.B.A was appointed independent director, effective August 31, 2023.
“On August 31, 2023, the Board of Directors (the "Board") of Karyopharm Therapeutics Inc. (the "Company") increased the size of the Board to nine members and, upon the recommendation of the Nominating, Corporate Governance & Compliance Committee of the Board, elected Zhen Su, M.D., M.B.A, as an independent director of the Company to fill the newly created vacancy.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-08-31–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Karyopharm Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Richard Paulson CEO, Board Member
- Senior Clinical CEO
- Michael Mano General Counsel
- Kristin Abate Chief Accounting Officer
- Barry E. Greene Board Member
- Chen Schor Board Member
- Christy J Oliger Board Member
- Christy J. Oliger Board Member
- Deepika R. Pakianathan Board Member
- Garen G. Bohlin Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.